News

In this article, Dr Johannson presents intraindividual IOL comparison follow-up results. Although similar levels of PCO development were observed for both AcrySof and Tecnis one-piece IOLs, fewer glistenings appeared in the Tecnis material, 3 years after implantation.

A protein called PKal (plasma kallikrein) and its associated molecules are key players in an inflammatory molecular pathway involved in diabetic macular edema, according to a study published in Diabetes.

A gaming headset is helping researchers address balance issues in patients who have glaucoma.

An interventional trial recently compared standard and navigated pattern PRP techniques. In this article, Dr Kozak explains how continuous prepositioning and stabilisation of the aiming beam with navigated PRP, enables pattern application of the more effective longer pulse durations while reducing treatment times and broadens therapeutic options in proliferative diabetic retinopathy.

In this article, Dr Tanna discusses treatment options for glaucoma patients who do not show satisfactory response to a PGA while taking into consideration the two key therapeutic choice factors: IOP-lowering efficacy and tolerability.

This follow-up study found anterior capsule opacification development and anterior capsule retraction to be more frequent 3 years after cataract surgery when an IOL with interrupted sharp optic edge at the optic–haptic junction is implanted, compared with an IOL with a continuous edge.

CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to the manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.

In this comparison study, IOP reductions were greater with BTFC than with TTFC and patients on this combination were more likely to achieve and maintain low target pressures. Combined BrTFC and DTFC may also be a more appropriate therapeutic choice for IOP lowering than TTFC and BrTFC, respectively.

One-year after implantation of the Cypass Micro-Stent, study results demonstrate a reduction in IOP and glaucoma medications, as well as a complete lack of sight-threatening adverse events. The implant is placed into the supraciliary space to facilitate suprachoroidal aqueous outflow in glaucoma patients.

Ophthalmologists are over-prescribing steroids to treat vernal keratoconjunctivitis (VKC) and causing an increase of steroid-induced glaucoma (SIG) in children, according to a recent study publish in the British Journal of Ophthalmology.

Learn about the effect of increased osmolarity on the corneal surface. This video provides insight into managing patients with hyperosmolarity and about the importance of testing in patients considering surgery.

In his latest blog, Mark Packer, MD, writes of a surgical tale that led him to discover aberrations can sometimes be your friend.

In preparation for U.S. News World & Report’s annual best ophthalmic hospitals for 2015-which will be announced next month-we have compiled the news site’s list of the top programs from last year. These 10 hospitals were coined the best for difficult cases and procedures by at least 5% of ophthalmology respondents to U.S. News’ surveys in 2012, 2013, and 2014.

The European Medicines Agency (EMA) has granted orphan drug designation to ISTH0036, a locked nucleic acid-modified antisense oligonucleotide under development by Munich-based Isarna Therapeutics, for the prevention of scarring after glaucoma filtration surgery (GFS).

Targeting the blood-vessel-growth protein angiopoietin-like 4 (ANGPTL4) along with anti-vascular endothelial growth factor (VEGF) therapy could increase the effectiveness of treatments for the prevention of proliferative diabetic retinopathy (PDR), according to researchers at The Johns Hopkins University and the University of Maryland.

As staff members develop in new roles, managers should coach and counsel them in the direction where they are thinking and making decisions in a global manner, not an individual manner.

The costs associated with medications for patients with glaucoma continue to have a significant effect on adherence. Making a switch from branded to generic drugs may make a difference for some patients in certain cases.